Mirati Therapeutics, Inc. MRTX
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 4.12B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -7.01
- Beta
- 0.77
- Short ratio
- 2.88
- Inst. own
- 117.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 27, 2024
- 50-d avg
- 57.93
- 200-d avg
- 45.92
- 1y target
- 64.50
5D chart
Chart tools
Chart is warming up
The five-day price history for MRTX has not been loaded yet. Try again in a moment.
Altman Z-Score
8.58 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -3.4×
P/S 205×
P/B 2.6×
P/FCF -4.4×
EV/EBITDA -3.1×
EV/Sales 190×
FCF Yield -22.6%
Gross Margin 95.2%
Operating Margin -6108.0%
Net Margin -5957.4%
ROE -74.3%
ROIC -72.3%
ROA -61.6%
Revenue -82.7%
Operating Income -32.5%
EPS (diluted) -17.6%
Free Cash Flow -44.4%
Current Ratio 7.0×
Quick Ratio 6.9×
Debt / Equity 0.1×
Net Debt / EBITDA 0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31